High Quality API Atomoxetine HCl CAS 82248-59-7

Product Details
Customization: Available
Powder: Yes
Customized: Non-Customized
Diamond Member Since 2019

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Terms of Payment
LC, T/T, D/P, PayPal, Western Union, Small-amount payment
International Commercial Terms(Incoterms)
FOB, CFR, CIF, DAT, FAS, DDP, DAP, CIP, CPT, FCA, EXW, Others
  • High Quality API Atomoxetine HCl CAS 82248-59-7
  • High Quality API Atomoxetine HCl CAS 82248-59-7
  • High Quality API Atomoxetine HCl CAS 82248-59-7
  • High Quality API Atomoxetine HCl CAS 82248-59-7
  • High Quality API Atomoxetine HCl CAS 82248-59-7
  • High Quality API Atomoxetine HCl CAS 82248-59-7
Find Similar Products

Basic Info.

Model NO.
201905140320
Certification
USP
Suitable for
Adult
State
Powder
Purity
>99%
Name
Atomoxetine HCl
Other Names
Atomoxetine HCl Capsules
Other Name
Atomoxetine HCl Powder
CAS
82248-59-7
Einecs
629-925-3
Molecular Formula
C17h22clno
Molecular Weight
291.82
Content
98%
Color
White
Form
Powder
Type
API
Grade
Pharma
MOQ
10g
Storage
Cool Dry Place
Shelf Life
2 Years
Transport Package
Foil Bag
Specification
99%
Trademark
TGYBIO
Origin
China
HS Code
2019051403
Production Capacity
20kg/Month

Product Description

High Quality API Atomoxetine HCl CAS 82248-59-7High Quality API Atomoxetine HCl CAS 82248-59-7

Topoxetine hydrochloride is a hydrochloride form of the nervous system medication topoxetine. It is a neurotransmitter reuptake inhibitor for the treatment of attention deficit hyperactivity disorder. Topoxetine is a selective norepinephrine reuptake inhibitor (SNRI) with a structure similar to fluoxetine. The drug, the first stimulant approved for attention deficit hyperactivity disorder (ADHD), has also not been shown in clinical trials to induce the typical response of other stimulants or drugs that can lead to feelings of euphoria. Randomized, placebo-controlled trials in children and adults have demonstrated its efficacy in treating ADHD. An open, open-label, randomized, controlled trial found the drug to be as effective in treating ADHD, but more randomized, double-blind clinical trials are needed to confirm this conclusion.

High Quality API Atomoxetine HCl CAS 82248-59-7

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier